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Abstract
Some inflammatory stimuli trigger activation of the NLRP3 inflammasome by inducing efflux of cellular potassium. Loss of
cellular potassium is known to potently suppress protein synthesis, leading us to test whether the inhibition of protein
synthesis itself serves as an activating signal for the NLRP3 inflammasome. Murine bone marrow-derived macrophages,
either primed by LPS or unprimed, were exposed to a panel of inhibitors of ribosomal function: ricin, cycloheximide,
puromycin, pactamycin, and anisomycin. Macrophages were also exposed to nigericin, ATP, monosodium urate (MSU), and
poly I:C. Synthesis of pro-IL-ß and release of IL-1ß from cells in response to these agents was detected by immunoblotting
and ELISA. Release of intracellular potassium was measured by mass spectrometry. Inhibition of translation by each of the
tested translation inhibitors led to processing of IL-1ß, which was released from cells. Processing and release of IL-1ß was
reduced or absent from cells deficient in NLRP3, ASC, or caspase-1, demonstrating the role of the NLRP3 inflammasome.
Despite the inability of these inhibitors to trigger efflux of intracellular potassium, the addition of high extracellular
potassium suppressed activation of the NLRP3 inflammasome. MSU and double-stranded RNA, which are known to activate
the NLRP3 inflammasome, also substantially inhibited protein translation, supporting a close association between inhibition
of translation and inflammasome activation. These data demonstrate that translational inhibition itself constitutes
a heretofore-unrecognized mechanism underlying IL-1ß dependent inflammatory signaling and that other physical,
chemical, or pathogen-associated agents that impair translation may lead to IL-1ß-dependent inflammation through
activation of the NLRP3 inflammasome. For agents that inhibit translation through decreased cellular potassium, the
application of high extracellular potassium restores protein translation and suppresses activation of the NLRP
inflammasome. For agents that inhibit translation through mechanisms that do not involve loss of potassium, high
extracellular potassium suppresses IL-1ß processing through a mechanism that remains undefined.
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Introduction
Aberrant interleukin-1ß (IL-1ß) signaling has been implicated in
a variety of inflammatory diseases ranging from arthritis to
diabetes, making the manipulation of the IL-1 pathway an
attractive therapeutic option for a growing number of pathologies
that stem from innate immune activation [1,2]. Critical to the
efficacy of the innate immune system is the proper detection of
invading microbes and toxic substances by macrophages that
express pattern recognition receptors (PRRs) in the cytosol and at
the cell surface. The Nod-like receptor (NLR) family member,
NLRP3, is a cytosolic PRR that is activated by a large array of
pathogen- and danger-associated molecular patterns to stimulate
IL-1ß processing by a multiprotein complex termed the inflam-
masome [3]. The NLRP3 inflammasome consists of NLRP3,
caspase-1, and the adaptor protein, ASC [3,4,5,6]. Bacterial pore-
forming toxins, viruses, asbestos, ATP, double-stranded RNA, and
uric acid crystals all stimulate IL-1ß processing via NLRP3
inflammasomes [6,7,8,9]. Although the importance of the
inflammasome in mediating the release of IL-1ß from cells is well
recognized, the mechanism(s) by which disparate activators trigger
inflammasome activation are incompletely understood.
In macrophages, proinflammatory signals are required to
mediate the expression of mRNA from the IL-1ß gene, resulting
in the accumulation of pro-IL-1ß protein. These initial, or
priming, signals are mediated by Toll-like receptor ligands such
as lipopolysaccharide (LPS), which direct the NF-kappaB-de-
pendent expression of pro-IL-1ß [3,10]. The proteolytic proces-
sing of pro-IL-1ß by caspase-1 and the subsequent release of IL-
1ß from cells requires a second signal to stimulate the assembly
of inflammasome complexes. Loss of intracellular potassium has
emerged as a frequent correlate of NLRP3 inflammasome
activation and has been proposed to constitute one such signal.
The conclusion that decreased intracellular potassium acts as
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was based initially on the observation that loss of potassium
induced by nigericin, a potassium ionophore, or by ATP results
in the robust release of IL-1ß from cells in an NLRP3-dependent
manner [7,11]. However, the mechanism by which loss of
intracellular potassium is linked with activation of the NLRP3
inflammasome is unclear. The production of reactive oxygen
species (ROS) as a result of mitochondrial dysfunction has also
been proposed as an activator of the NLRP3 inflammasome
[8,11,12,13], although the validity of this conclusion has been
questioned [14,15,16].
It has been shown that sufficient levels of potassium are required
for elongation of the peptide chain on the ribosome in vitro
[17,18,19,20] and that reduced concentrations of intracellular
potassium fail to support protein synthesis in mammalian cells
[20,21]. Recently, we reported that ricin toxin, a well-defined
inhibitor of protein synthesis, leads to IL-1ß- and macrophage-
dependent inflammation when delivered to the lungs of mice [22].
By examining ricin-mediated release of IL-1ß from primary bone
marrow-derived macrophages (BMDM), we found that the release
of IL-1ß from BMDM requires the known components of the
NLRP3 inflammasome: NLRP3, caspase-1, and ASC [23]. This
finding led us to test whether inhibition of protein translation per se
could constitute a signal that is sufficient to activate the NLRP3
inflammasome.
Here we employed a panel of well characterized protein
synthesis inhibitors and found that each inhibitor induced the
release of IL-1ß from LPS-primed BMDM in a manner that
was dependent on the NLRP3 inflammasome. In BMDM
treated with inhibitors of protein synthesis, intracellular potas-
sium concentrations remained constant during the time in
which IL-1ß release was observed from these cells, suggesting
that activation of the NLRP3 inflammasome did not result from
loss of potassium. To address whether inhibition of protein
synthesis is a common feature of NLRP3 inflammasome
activation, we examined two clinically relevant inflammasome
triggers, monosodium urate, which causes inflammatory gout,
and poly I:C, which mimics the proinflammatory actions of
viral dsRNA. We report that monosodium urate and poly I:C
each suppressed protein synthesis at doses and times that
correspond with the release of IL-1ß from BMDM. We treated
BMDM with NLRP3 stimuli in the presence of proteasome
inhibitors, and found that proteasome activity was required for
the ability of translational inhibitors, including MSU and poly
I:C, to induce IL-1ß secretion from cells.
Our results demonstrate that impaired ribosomal function may
constitute a common mechanism of NLRP3 inflammasome
activation through a process that may require proteasomal activity.
These studies further suggest that decreased cellular potassium may
trigger IL-1ß release by inhibiting protein translation.
Results
Activation of the NLRP3 Inflammasome by Inhibitors of
Translation
We tested the ability of a panel of well-characterized
inhibitors of translation (cycloheximide, emetine, puromycin,
pactamycin, and anisomycin) to stimulate IL-1ß release from
BMDM via the NLRP3 inflammasome. When added at doses
that suppress incorporation of [
3H]-leucine by at least 90%,
each inhibitor led to release of IL-1ß from LPS-primed BMDM
by 4 h (Fig. 1A). Conversion of pro-IL-1ß to IL-1ß induced by
cycloheximide proceeded in a dose-dependent manner (Fig. 1B),
suggesting that the degree of translational impairment correlated
well with the amount of IL-1ß that was released. As expected,
there was a reciprocal relationship between the amount of pro-
IL-1ß present in the cell lysate (Fig. 1A, upper panel) and the
amount of IL-1ß detected in the culture medium by ELISA
(Fig. 1A, lower panel). Cells remained strongly adherent to
culture dishes at the termination of the experiments, and did
not show morphological signs of apoptosis or activation of
caspase-3 (not shown). To gain insight into the mechanism of
IL-1ß release triggered by translational inhibitors, we exposed
BMDM from mice deficient in NLRP3, ASC, or caspase-1 to
agents that inhibited translation by a variety of mechanisms and
compared their responses to those of wild-type (WT) cells.
When BMDM deficient in NLRP3, ASC, or caspase-1 were
exposed to the inhibitors, the cells secreted substantially reduced
amounts of IL-1ß compared with WT BMDM exposed to the
same inhibitors (Fig. 1C), suggesting that processing and release
of IL-1ß were mediated through formation of the NLRP3
inflammasome.
Extracellular Potassium Suppresses Release of IL-1ß
Induced by Inhibitors of Translation
Previous studies have described a requirement for potassium
efflux by a variety of agents reported to activate the NLRP3
inflammasome, including nigericin and ATP [11]. Here, sub-
stitution of 130 mM Na
+/5 mM K
+ by 5 mM Na
+/130 mM K
+
in the culture medium suppressed the appearance of mature IL-1ß
by translation inhibitors to a similar extent as nigericin and ATP,
as detected by ELISA (Fig. 2A). Immunoblotting of the high
potassium culture medium revealed undetectable amounts of
mature IL-1ß in the culture medium of LPS-primed cells exposed
to nigericin or ATP (Fig. 2B), or ricin, emetine, or cycloheximide
(Fig. 2C).
Lack of Correlation between Translation Inhibition and
Potassium Efflux
The ability of high extracellular potassium to suppress activation
of the NLRP3 inflammasome by multiple proinflammatory
agonists [11] has been used to support a model demonstrating
that decreased cellular potassium constitutes a general trigger for
inflammasome activation. Initial studies were conceived because
nigericin and ATP, agents that are known to cause potassium
efflux [7,24], are also potent activators of the NLRP3 inflamma-
some. The conclusion that loss of cellular potassium is responsible
for activation of the NLRP3 inflammasome was based on the
ability of high extracellular potassium to suppress pro-IL-1ß
processing and release of mature IL-1ß in the presence of high
potassium [11]. Subsequent studies have employed high extracel-
lular potassium to block activation of the NLRP3 by a variety of
agents [13,25,26,27,28,29,30]. Although these studies demonstrat-
ed that high extracellular potassium blocks release of IL-1ß, they
did not determine whether the proinflammatory agents employed
actually cause a loss of cellular potassium.
To determine whether inhibition of translation would trigger
efflux of potassium from macrophages, we exposed LPS-primed
BMDM to emetine, a potent inhibitor of translation [31,32] that
irreversibly inhibits the elongation cycle of translation by greater
than 99% within 1 minute [33] and produces release of IL-1ß
within 4 h. Intracellular potassium was measured by inductively
coupled plasma mass spectroscopy (ICP-MS). Nigericin and ATP,
agents that have been shown to reduce intracellular potassium
[7,24], produced a 50% decrease in intracellular potassium
concentration by 15 min and 45 min, respectively (Fig. 3A).
BMDM exposed to nigericin and ATP detached from the culture
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normal levels of intracellular potassium for at least 4 h (Fig. 3A).
Ricin and cycloheximide similarly failed to cause release of cellular
potassium (not shown). These data suggest that in BMDM the
inhibition of translation promoted the activation of the NLRP3
inflammasome but failed to induce leakage of cellular potassium in
the interval of time (4 h) that preceded activation of the
inflammasome and release of IL-1ß.
Four h after exposure of LPS-primed BMDM to emetine in
medium containing low potassium, both IL-1ß and a proteolytic
fragment of caspase-1 (p10) appeared in the medium (Fig. 3B, 2nd
lane). In the presence of elevated potassium, neither p10 capase-1
nor IL-1ß appeared in the medium of cells exposed to emetine
(Fig. 3B, 4th lane), suggesting that high potassium blocked caspase-
1-mediated processing of pro-IL-1ß.
Coupling between Potassium Efflux and Inhibition of
Protein Translation
In view of the differential requirement for potassium efflux in
promoting NLRP3 activation, we sought to determine whether
nigericin, ATP, and panel of translation inhibitors that we
employed shared any mechanistic features. It has been well
established that the rate of protein synthesis is directly dependent
on the concentration of intracellular potassium [18,34] and that
potassium ionophores inhibit translation at the same doses and
kinetics as potassium efflux [35]. To test the ability of nigericin and
ATP to suppress protein synthesis in BMDM, we subjected cells to
nigericin or ATP and measured incorporation of [
3H]-leucine.
Exposure of BMDM to either nigericin or ATP triggered rapid
inhibition of protein synthesis by 30 min in normal medium
(130 mM Na
+/5 mM K
+; Fig. 3C). Replacement of extracellular
Na
+ by K
+ (130 mM K
+/5 mM Na
+) partially reversed the
blockade of protein synthesis in ATP-treated cells. Replacement of
extracellular Na
+ by K
+ in nigericin-treated cells restored protein
synthesis to a level even greater than that observed in untreated
cells (Fig. 3C). These data are consistent with the known
association of decreased cellular potassium with the inhibition of
protein synthesis by nigericin, ATP, and other potassium
ionophores [34,35,36].
Figure 1. Inhibition of protein synthesis triggers secretion of IL-1ß from primed BMDM. A) WT BMDM were stimulated or not with 50 ng/
ml LPS for 4 h followed by exposure to 10 mg/ml ricin, 25 mg/ml cycloheximide, 10 mg/ml emetine, 75 mg/ml puromycin, 0.2 mg/ml pactamycin, or
10 mg/ml anisomycin for 4 h prior to harvesting. Cell extracts were analyzed by immunoblotting for p38 MAPK (loading control) and pro-IL-1ß (upper
panel). Media supernatants were analyzed by ELISA for released IL-1ß (lower panel). ELISA data are represented as mean 6 SEM from triplicate dishes.
B) LPS-primed WT BMDM were stimulated for 4 h with increasing doses of cycloheximide (from right to left: 0.03, 0.1, 0.3, 1.0, 3.0, 10, 30, and 100 mg/
ml). Media supernatants were analyzed by ELISA for released IL-1ß (upper panel). Cell extracts were analyzed by immunoblotting for p38 MAPK
(loading control) and pro-IL-1ß (lower panel). ELISA data are represented as mean 6 SEM from triplicate dishes. C) Release of IL-1ß triggered by
inhibitors of translation was determined by immunoblotting of cell extracts (cell) or culture medium (medium) from LPS-primed BMDM obtained
from WT mice or mice deficient in NLRP3, ASC, or caspase-1, as indicated. P38 MAPK was loading control.
doi:10.1371/journal.pone.0036044.g001
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Gout is a chronic inflammatory response that is associated with
the formation of crystals of monosodium urate (MSU). Incubation
of LPS-primed murine macrophages with MSU crystals leads to
the conversion and release of IL-1ß by a process that requires
activation of the NLRP3 inflammasome. Because increased
extracellular potassium blocks the activation of the NLRP3
inflammasome by MSU, it has been concluded that MSU acts
through a mechanism that involves a decreased concentration of
cellular potassium [11,37,38]. To determine if MSU inhibits
protein synthesis at doses that stimulate release of IL-1ß from
BMDM, we exposed cells to increasing doses of MSU or
monopotassium urate (MPU), a salt of uric acid that is ineffective
in promoting IL-1ß release [38]. The secretion of mature IL-1ß
Figure 2. Effect of extracellular potassium on IL-1 processing and release. A) Bone marrow-derived macrophages were plated in triplicate
wells in 12-well plates and primed with 50 ng/ml of LPS for 4 h. Cells were then incubated in medium containing 130 mM NaCl/5 mM KCl or 5 mM
KCl/130 mM NaCl in the presence of absence of 0.01 mg/mL ricin, 25 mg/mL cycloheximide, 10 mg/mL, 10 mg/mL emetine, 75 mg/mL puromycin,
0.2 mg/mL pactamycin, 10 mg/mL anisomycin, 3.4 mM nigericin, or 5 mM ATP for 4 h. Medium was collected, and p17 IL-1 was determined by ELISA. B)
Macrophages were plated, primed with LPS and incubated in medium containing 130 mM NaCl/5 mM KCl (MEM-Na) or 5 mM NaKCl/130 mM KCl
(MEM-K) in the presence or absence 5 mM ATP or 3.4 mM nigericin for 4 h. Proteins were precipitated from the media with TCA and analyzed by
Western blotting. C) Macrophages were plated, primed with LPS, and incubated in medium containing 130 mM NaCl/5 mM KCl (MEM-Na) or 5 mM
NaKCl/130 mM KCl (MEM-K) in the presence or absence 10 ng/mL ricin, 10 mg/mL emetine, or 25 mg/mL cycloheximide for 4 h. Proteins were
precipitated with TCA and analyzed by Western blotting.
doi:10.1371/journal.pone.0036044.g002
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manner with inhibition of [
3H]-leucine incorporation into BMDM
(Fig. 4A,B). Monopotassium urate (MPU), which, as expected,
failed to stimulate conversion of pro-IL-1ß to mature IL-1ß
(Fig. 4B), also failed to inhibit protein synthesis as measured by
incorporation of [
3H]-leucine (Fig. 4A). These results demonstrat-
ed that MSU-induced suppression of protein synthesis in
macrophages correlated with the release of IL-1ß by MSU.
Double-stranded RNA Inhibits Protein Translation and
Activates the NLRP3 Inflammasome
Many forms of cellular stresses, including exposure to dsRNA
and accumulation of unfolded proteins [39], activate pathways
that lead to the phosphorylation of the translation initiation factor
eIF-2alpha on serine 51. Phosphorylation of eIF-2alpha on serine
51 results in global, frequently transient, inhibition of protein
synthesis [39]. Intracellular poly I:C, an analog of dsRNA
employed experimentally to mimic the effects of viral dsRNA in
cells, has been shown to activate the NLRP3 inflammasome in
BMDM [6]. Indeed, exposure of BMDM to poly I:C induced the
release of IL-1ß from primed BMDM as well as the phosphor-
ylation of eIF-2alpha on serine 51 (Fig. 5A). The release of IL-1ß
from primed BMDM induced by poly I:C was accompanied by
inhibition of protein synthesis (Fig. 5B).
Proteasome Inhibitors Block Activation of the NLRP3
Inflammasome
Previously we showed that inhibitors of proteasome activity
reduce the ricin-mediated activation of the NLRP3 inflammasome
in LPS-primed BMDM [22]. Others have reported that protea-
some inhibitors reduce the activity of the NLRP1 inflammasome
but not the accumulation of pro-IL-1ß by anthrax lethal toxin
[40]. To determine if proteasome inhibitors would block the ability
of translation inhibitors to activate the NLRP3 inflammasome, we
employed two proteasome inhibitors, MG-132 and bortezimib. IL-
1ß release mediated by cycloheximide or ricin was strongly
suppressed in LPS-primed BMDM co-treated with either
bortezimib or MG-132 (Fig. 6A). Inclusion of MG-132 blocked
the ability of each of the translation inhibitors to induce the
processing of pro-IL-1ß and the release of IL-1ß from cells
(Fig. 6B). MG-132 similarly suppressed the release of IL-1ß from
cells exposed to MSU (Fig. 6C) and poly I:C (Fig. 5A), suggesting
that proteasomes may participate more generally in activation of
the NLRP3 inflammasome.
Discussion
Ricin is a potent ribosomal toxin considered to be a potential
bioterrorist agent due to the possibility of aerosol delivery to
human populations [41]. Studies in animals demonstrated that
delivery of ricin to the pulmonary system leads to acute lung injury
and symptoms resembling acute respiratory distress syndrome
[42,43,44,45]. Previously we reported that the inflammatory and
lethal effects of inhaled ricin were prevented in mice with a genetic
deficiency in IL-1ß. Lung inflammation was blocked in mice that
had been co-treated with IL-1 receptor antagonist (IL1RA;
anakinra) or depleted of macrophages, suggesting the primacy of
macrophage-derived IL-1ß in orchestrating pulmonary inflamma-
tory responses to ricin [22]. Exposure of LPS-primed BMDM to
ricin in vitro induced the processing pro-IL-1ß to mature IL-1ß in
a NLRP3 dependent manner [23], raising the possibility that the
toxic action of ricin on ribosomal function was responsible for
activation of the NLRP3 inflammasome.
These results prompted us to examine the role that suppression
of ribosomal activity plays in facilitating initiation of inflammatory
Figure 3. Inhibition of protein synthesis fails to elicit efflux of potassium from cells. A) Intracellular potassium in WT BMDM was analyzed
by ICP-MS after priming with LPS for 4 h and exposure to emetine, ATP, and nigericin for indicated times. Data are represented as mean 6 SEM from
triplicate dishes. Measurements of potassium release by cells exposed to ATP and nigericin were terminated at 10 min and 60 min, respectively, as
a result of cytotoxicity and detachment of cells from the dishes. Cells exposed to emetine showed no signs of cytotoxicity or detachment by 4 h. B)
Elevated potassium blocks emetine-mediated release of IL-1ß and processing of caspase-1. LPS-primed BMDM were either exposed or not exposed to
10 mg/ml emetine for 4 h, at which time proteins were precipitated from the media with TCA and analyzed by Western blotting as shown. C) BMDM
in triplicate wells were pulse-labeled in medium containing [
3H]-leucine for 15 min prior to harvest at the indicated times and the amount of [
3H]-
leucine incorporation was measured.
doi:10.1371/journal.pone.0036044.g003
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that a panel of translation inhibitors, acting through different
mechanisms on peptide initiation or elongation, promoted the
conversion and release of IL-1ß by a process that required
participation of the NLRP3 inflammasome (Fig. 1). These data led
us to question whether inhibition of translation, which occurs as
a result of a variety of cellular stresses, might serve as a relevant
trigger for inflammasome activation in human inflammatory
disease.
It has been proposed that decreased levels of intracellular
potassium act to trigger release of IL-1ß as a result of activation of
the NLRP3 inflammasome [11]. It is well documented that
reduced concentrations of intracellular potassium also fail to
support protein synthesis in mammalian cells [20,21]. Potassium
ionophores such as nigericin and valinomycin and compounds that
poison the membrane-associated Na
+/K
+ ATPase rapidly trigger
translational inhibition in cells concomitant with efflux of cellular
potassium, and application of high extracellular potassium is
sufficient to rescue ribosomal activity [21,36,46,47]. Replacement
of extracellular sodium with potassium suppresses the ability of
nigericin and ATP to activate the NLRP3 inflammasome,
supporting the notion that low intracellular potassium serves as
a trigger for inflammasome activation [11]. Our results demon-
strating the rescue of protein translation by increased extracellular
potassium in BMDM exposed to nigericin or ATP (Fig. 3C)
suggested to us that impairment of ribosomal activity may explain
why loss of cellular potassium activates the NLRP3 inflammasome.
However, the inability of emetine, a potent and irreversible
inhibitor of protein synthesis, to promote efflux of potassium
(Fig. 3A) demonstrated that an intracellular environment of low
potassium was not required for activation of the NLRP3
inflammasome by molecules that directly interfere with ribosomal
function.
It has been concluded that MSU crystals activate the NLRP3
inflammasome [48] through a process that leads to decreased
concentration of cellular potassium [11,38]. The conclusion that
decreased concentration of cellular results from a leakage of
potassium from cells after MSU treatment was based on the ability
of high extracellular potassium (150 mM) to block processing of
pro-IL-1ß to its active form [11]. Exposure of BMDM to MSU
results in the engulfment of the insoluble crystals within the acidic
milieu of endosomes [38], resulting in solubilization of the crystals
and the subsequent rapid increase in cellular volume caused by
release of sodium ions. The increase in cellular volume is thought
to be responsible for a drop in concentration of intracellular
potassium by dilution [38]. Our results showing that exposure of
BMDM to MSU, but not MPU, results in the dose-dependent
inhibition of protein translation and release of IL-1ß (Fig. 2), is
consistent with the latter model and further supports the close
association between inhibition of protein translation and activation
of the NLRP3 inflammasome.
In view of our data showing that inhibition of translation fails to
mediate loss of cellular potassium (Fig. 3), we were surprised that
high extracellular potassium was able to block appearance of IL-
1ß in the medium. Interestingly, Arlehamn et al. reported that
high extracellular potassium inhibited IL-1ß release from cells
after bacterial infection with P. aeruginosa and S typhimurium, which
was dependent on the NLRC4 inflammasome, but that potassium
leakage from cells could not be detected by flame photometry [49].
They conjectured that a minority of cells had undergone a loss of
potassium due to the nature of the pathogens, which did not infect
every cell, and for this reason they could not observe measurable
potassium loss from the population of cells. Alternatively, high
extracellular potassium may block the release of IL-1ß by
a mechanism that is independent of intracellular potassium
concentration. For example, high potassium (150 mM) has been
shown to suppress activation and cleavage of recombinant caspase-
1 in vitro [50]. Petrilli et al reported that MSU-treated primed
macrophages release pro-IL-1ß and procaspase-1 into the
medium, and that cells exposed to high extracellular potassium
release pro-IL-ß and procaspase-1 into the high potassium
medium, but that proteolytic processing of these proteins failed
to occur [11]. These data and our data (Fig. 3B) suggest that high
extracellular potassium may directly suppress the cleavage of pro-
IL-1ß after externalization of the inflammasome complex by
inhibiting the activation of procaspase-1. Our data suggest that
cells in high potassium may suppress the activation of the NLRP3
inflammasome by two independent mechanisms: 1) by restoring
intracellular potassium to normal levels in cells that have
undergone leakage of potassium via pore formation (e.g. by
nigericin) or stimulation of P2X7 receptors (e.g. by ATP), thereby
preventing translational inhibition; and 2) by suppressing the
activation of caspase-1 by an unknown mechanism.
The generation of reactive oxygen species (ROS) is commonly
associated with NLRP3 inflammasome activation in response to
a variety of agonists, including the mitochondrial inhibitors,
rotenone and antimycin A [8,11,12,13]. However, the conclusion
that generation of ROS is responsible for inflammasome activation
Figure 4. MSU crystals inhibit protein synthesis at concentra-
tions that induce processing and release of IL-1ß. WT BMDM
were primed with LPS for 4 h prior to exposure MSU or MPU at
indicated concentrations. A) BMDM in triplicate wells were pulse-
labeled in medium containing [
3H]-leucine for 15 min prior to harvest at
the indicated times and the amount of [
3H]-leucine incorporation was
measured. B) Cells were harvested 4 h after addition of indicated
concentrations of MSU and MPU. Cell lysates (cell) and culture medium
(medium) were examined by immunoblotting. P38 MAPK was loading
control.
doi:10.1371/journal.pone.0036044.g004
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Complex I or Complex III following exposure of cells to rotenone
or antimycin A, respectively, leads to the generation of ROS
through loss of mitochondrial membrane potential [51,52,53].
Rotenone and antimycin A have been shown to activate the
NLRP3 inflammasome, presumably as a result of ROS pro-
duction, since treatment of macrophages with Mito-Tempo,
a scavenger of mitochondrial ROS, inhibited inflammasome
activation [54]. Uncouplers of mitochondrial function such as
rotenone and antimycin A are also potent inhibitors of translation,
reducing the protein synthetic rate by more than 90% at
concentrations employed to generate ROS in cultured cells
[36,55].
Several reports have demonstrated that ROS can inhibit
mRNA translation [56,57,58]. Although the mechanism by which
mitochondrial inhibitors inhibit protein synthesis is incompletely
understood, it has been shown recently that mitochondrial
inhibitors suppress protein synthesis by inducing the rapid
phosphorylation of both eIF-2alpha and the elongation factor
eEF2, presumably by stimulating PERK [59]. Indeed, peroxide-
and hypoxia-mediated ROS have been shown to inhibit trans-
lation by increasing PERK- and PKR-mediated phosphorylation
of eIF-2alpha and eEF2 [60]. Our data demonstrating that
inhibition of translation can activate the NLRP3 inflammasome is
consistent with the notion that the generation of ROS by
mitochondrial dysfunction may activate the NLRP3 inflamma-
some by suppressing protein synthesis through stress-activated
phosphorylation of eIF-2alpha and eEF2.
Inhibition of translation occurs in a variety of circumstances
in nature, triggered by exposure to toxins, pathogens that co-opt
host cell machinery, hypoxia, and sterile inflammatory signals
released from damaged tissues. Phosphorylation of eIF-2alpha at
Ser51 mediates translational inhibition in response to cellular
signals [61,62] by preventing the formation of the eIF2/GTP/
Met-tRNA complex [63]. Stress-induced inhibition of translation
through phosphorylation of eIF-2alpha is induced by viral
dsRNA through activation of protein kinase R (PKR); hypoxia
through the PRK-like endoplasmic reticulum kinase (PERK);
and by glucose deprivation through activation of both PKR and
PERK [39,64,65,66]. An important consequence of eIF-2alpha
phosphorylation is the regulation of gene expression, as
mutations that interfere with eIF-2alpha phosphorylation lead
to defective expression of stress-induced genes [67]. Recent
evidence suggests that PKR acts as a central integrator in the
inflammatory component of metabolic control by linking
nutrient- and pathogen-sensing pathways in development of
insulin resistance, type 2 diabetes, and other chronic metabolic
pathologies [68]. Poly I:C-mediated activation of the NLRP3
inflammasome has been previously reported [6]. In LPS-primed
BMDM we found that poly I:C mediates eIF-2alpha phosphor-
ylation, inhibition of protein synthesis, and the release of IL-1ß
(Figure 5). Phosphorylation of eIF-2alpha is required not only
for attenuation of translation, but also for transcriptional
induction and survival in response to endoplasmic reticulum-
mediated stress (ER stress) [67]. ER stress activates the NLRP3
inflammasome via a pathway that does not involve the unfolded
protein response [27]. Repression of translation through
phosphorylation of eIF-2alpha leads to activation of NF-kappaB
and the subsequent transcription of NF-kappaB-directed genes
by promoting the turnover of the labile inhibitor, IkappaB alpha
protein [69]. Stress-induced translational inhibition by phos-
phorylated eIF-2alpha may contribute to inflammatory re-
sponses by simultaneously promoting the two necessary events
required to produce IL-1ß: the NF-kappaB-mediated synthesis
of pro-IL-1ß and the release of IL-1ß through activation of the
NLRP3 inflammasome. This model could explain how stress
signals that converge on eIF-2alpha could induce IL-1ß-
dependent inflammatory responses.
Figure 5. Inhibition of protein synthesis by dsRNA and inhibition of IL-1ß processing by MG-132. A) BMDM were treated with or without
4 h of LPS priming, as indicated. Cells were then rinsed in fresh medium and treated with either LipofectAMINE 2000 or LipofectAMINE 2000-poly I:C
complex for 4 h, in the presence or absence of 30 mM MG-132, as indicated. Cell lysates (cell) or media (medium) samples were subjected to
immunoblotting with the antibodies indicated. B) BMDM were treated with either LipofectAMINE 2000 alone or with LipofectAMINE 2000-dsRNA
complex for the times indicated. Fifteen minutes before each time-point, 1 mCi of [
3H]-leucine was added, and leucine incorporation was terminated
by trichloroacetic acid. Each treatment was conducted in triplicate wells, and values are shown as mean 6 S.D. Percent incorporation of [
3H]-leucine
at each point was calculated as the [
3H]-leucine incorporated into cells exposed to LipofectAMINE 2000-dsRNA complex/[
3H]-leucine incorporated
into cells exposed to LipofectAMINE 2000 alone6100.
doi:10.1371/journal.pone.0036044.g005
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short half-lives, such as p53 and IkappaB, is frequently regulated
by the balance between their rate of synthesis and proteasome-
directed degradation [70,71,72]. For example, inhibition of
protein translation by stress-induced phosphorylation of eIF-
2alpha leads to activation of NF-kappaB through proteasome-
dependent degradation of IkappaB [69,73]. Our experiments
determined that co-treatment of BMDM with proteasome
inhibitors plus ricin, cycloheximide, puromycin, pactamycin,
anisomycin, MSU, or dsRNA led to a reduction or complete
suppression of IL-1ß release as measured by ELISA (Figure 4A) or
immunoblot (Figures 4B, 5). LPS-primed cells treated with poly
I:C in the presence of MG-132 exhibited a reduction in IL-1ß
release but did not change the phosphorylation status of eIF-
2alpha (Fig. 5), suggesting that involvement of the proteasome in
activating the inflammasome is positioned downstream of trans-
lational inhibition in these cells.
In light of our data showing a link between suppression of
protein synthesis and activation of the NLPR3 inflammasome, we
propose that labile protein(s) may suppress the formation of the
NLRP3 inflammasome. In such a scenario, inhibition of trans-
lation, which accompanies many types of cellular stresses, would
lead to a decrease in abundance of putative repressor protein(s),
perhaps through proteasome-mediated degradation. In this model,
blockade of proteasomal activity would extend the lifetime of the
putative repressor protein(s). The validity of this model would
require identification of labile protein(s) that inhibit the processing
of pro-IL-1ß.
The current study demonstrates that suppression of ribosomal
function by molecules acting by disparate mechanisms is sufficient
to activate the NLRP3 inflammasome. These data suggest that
inhibition of translation may constitute a common stimulus by
which seemingly dissimilar activators promote the processing and
release of IL-1ß. A decreased rate of translation may constitute
a regulatory node that integrates signals from toxins, pathogens,
and metabolic disturbances, thereby enhancing systemic inflam-
mation by promoting the processing and release of IL-1ß. The
suppression of IL-1ß release by proteasome inhibitors suggests that
labile protein(s) may be responsible for blocking the activation of
the NLRP3 inflammasome under non-stressed conditions. A
decrease in translation rate may lead to reduction in cellular levels
of these protein(s), thereby leading to formation of active NLRP3
inflammasomes. Further studies that focus on identification of
labile inhibitors of inflammasome function are clearly necessary to
test the validity of this hypothesis. A graphic depiction of the
proposed mechanisms underlying NLRP3 activation by different
stimuli is shown in Figure 7.
Materials and Methods
Ethics Statement
This study was approved by the Institutional Animal Care &
Use Committee (IACUC) and the Institutional Biosafety Com-
mittee of OHSU. The authors have conformed to the policies of
the Institutional Office of Integrity of OHSU. Mice are
anesthetized with ketamine/xylazine. To minimize pain and
discomfort, mice are euthanized by cervical dislocation as per the
recommendation of the Panel of Euthanasia of the American
Veterinary Medical Association. Only personnel trained in animal
experimentation are involved. All procedures that involve the use
of ricin and animals have been approved by the Chemical Safety
Officer at OHSU and by the Institutional Animal Care Utilization
Committee (IACUC) at OHSU. Personnel are gloved and wear
protective coverings over their body, including full face respirator
Figure 6. Proteasome inhibitors block processing and release
of IL-1ß. A) LPS-primed WT BMDM were incubated in control medium
or medium containing 10 ng/ml ricin or 25 mg/ml cycloheximide for
4 h. MG-132 (30 mM) or Bortezimib (0.5 mM) was included as indicated.
Secreted IL-1ß was measured by ELISA in triplicate wells. B) LPS-primed
WT BMDM were incubated in the presence or absence of MG-132 for 4
hours, in the presence or absence of inhibitors of protein synthesis, as
indicated. Cell lysates (cell) and culture medium (medium) were
examined by immunoblotting. C) LPS-primed or unprimed WT BMDM
were or exposed to MSU, MG-132, or both for 4 h, as indicated. Cell
lysates (cell) and culture medium (medium) were examined by
immunoblotting.
doi:10.1371/journal.pone.0036044.g006
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Animals are housed in designated areas as approved by the
IACUC under protocol A900, OHSU.
Reagents and Antibodies
Cycloheximide, emetine, anisomycin, and puromycin were
purchased from Sigma-Aldrich (St. Louis). Ricin was purchased
from Vector Laboratories (Burlingame, CA). Polyinosinic-cytidylic
acid (Poly I:C) was purchased from Midland Certified Reagents
(Midland, Texas). Lipofectamine 2000 was purchased from Life
Technologies (Carlsbad, CA). Bortezimib was purchased from LC
Laboratories (Woburn, MA). MG-132 was purchased from EMD
Biosciences (Gibbstown, NJ). Pactamycin was a gift from the
Upjohn Company (Kalamazoo, MI). Anti-IL-1ß was purchased
from Abcam (Cambridge, MA) and anti-p38 MAPK was
purchased from Santa Cruz Biotechnology (Santa Cruz, CA).
Anti-phospho-eIF-2alpha (ser51) #9721 was purchased from Cell
Signaling (Danvers, MA). The mouse IL-1ß enzyme-linked
immunosorbent assay (ELISA) Ready-Set-Go was purchased from
eBioscience (San Diego, CA). Crystals of MSU and MPU were
prepared as described [74].
Animals and Animal Procedures
All animal procedures were performed according to protocols
that have been approved by the Institutional Animal Care and Use
Committee at Oregon Health and Science University, Portland,
Oregon. C57BL/6J and caspase-1 deficient mice were purchased
from the Jackson Laboratory (Bar Harbor, ME). ASC- and
NLRP3-deficient mice were kindly provided by V. Dixit
(Genentech, San Francisco, CA). Male mice, 8–10 weeks of age,
were used throughout the experiments.
Isolation of Bone Marrow- Derived Macrophages (BMDM)
Male mice, 8 to 10 weeks of age, were used throughout the
experiments. Cells were prepared from WT C57BL/6J, ASC-,
Caspase-1-, and NLRP3-deficent mice. Marrow was flushed from
femurs and tibias with PBS and cultured in alpha-Minimum
Essential Medium (aMEM, Cellgro, Herndon, VA), supplied with
10% Fetal Bovine Serum (FBS, Cellgro, Herndon, VA), 50 mg/ml
gentamicin, and 100 ng/ml recombinant mouse Colony Stimu-
lating Factor 1 (CSF-1, R&D Systems, Minneapolis, MN) for
72 hrs on non-tissue culture treated 10-cm Petri dishes. BMDM
were passaged and cultured for an additional 72 h. Each confluent
10-cm dish was transferred into one 6-well or one 12-well tissue
culture plate and cultured for 24 hrs before initiating experimental
treatment.
Treating BMDM
Cells were serum deprived in alpha-MEM for 30 minutes
followed by treatment for 4 hours in the presence or absence of
50 ng/mL LPS. Cells were then rinsed and fresh media was added
followed by exposure to the indicated doses of inhibitors (or solvent
control), in the absence of LPS, for 4 hrs. In experiments
Figure 7. Graphic depiction of proposed mechanisms by which different stimuli activate the NLRP3 inflammasome. Inhibition of
protein synthesis leads to activation of the NLRP3 inflammasome by preventing the synthesis of short-lived inhibitory protein(s) that are degraded by
proteasomes. Inhibition of protein synthesis is mediated by a variety of physiological cell stressors acting through phosphorylation of eIF-2alpha,
leading to a transient decrease in protein synthesis. Toxins such as ricin, Shiga toxins, and sarcin inhibit protein synthesis by interfering with the
structure of the sarcin/ricin loop of 28S rRNA. Antibiotics act through various ribosome-associated mechanisms to inhibit translational initiation and/
or elongation. Potassium ionophores (and receptors such as P2X7) inhibit translation by mediating loss of cellular potassium. Monosodium urate
inhibits translation by inducing cell swelling, which leads to dilution of intracellular potassium.
doi:10.1371/journal.pone.0036044.g007
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at an equivalent molar concentration.
Immunoblotting
BMDM cells were lysed in 26ESB lysis buffer in preparation for
immunoblotting. Equal volumes of the cell lysates were separated
on a 10% denaturing polyacrylamide gel in the presence of sodium
dodecyl sulfate and were transferred onto polyvinylidene difluoride
membranes according to standard laboratory procedures. For
detection of IL-1ß released from cells, proteins from media
supernatants were precipitated using TCA plus 200 mg insulin
carrier protein and separated on 13% gels. Membranes were
incubated with the indicated antibodies and the corresponding
horseradish peroxidase-conjugated secondary antibodies. Signals
were detected by using enhanced chemiluminescence.
ELISA
Media from BMDM were collected and analyzed in triplicate
using IL-1ß ELISA (eBioscience) according to the manufacturer’s
protocol.
ICP-MS
Primed BMDM were exposed to inhibitors of protein synthesis
for indicated times up to 4 h and cells were digested overnight in
culture dishes in 1 mL 10% HNO3. Digests were analyzed by
inductively coupled plasma mass spectrometry (ICP-MS) in the
Metal Ion Core by Dr. Martina Ralle in the Department of
Biochemistry and Molecular Biology at OHSU. ICP-MS analysis
was performed using an Agilent 77006system equipped with an
ASX-250 Autosampler. The system was operated at a radio
frequency power of 1,550 W, an argon flow rate of 15 L/min,
carrier gas flow rate of 1.04 L/min, and helium (He) gas flow rate
of 4.3 ml/min (only in He mode). Data were quantified using
a seven-point (0, 1, 10, 100, 1,000, 2,000, and 5,000 ppb (ng/g))
calibration curve with an external standard for potassium. All data
were acquired in He mode to remove interference from oxides,
argides, and chlorides. For each sample, data were acquired in
triplicate and averaged. Internal standards introduced with the
sample were used to correct for plasma instabilities. A National
Institute of Standards and Technology standard reference material
(SRM 1577c) was used to ensure elemental recovery of .90%.
Measurement of Protein Synthesis via Incorporation of
[
3H]-leucine
BMDM were cultured in 24-well tissue culture plates. Treat-
ments were performed in leucine-free/serum-free Dulbecco
modified Eagle medium, for the indicated times. Prior to
harvesting, the cells were pulse-labeled with 1 mCi of [
3H]-leucine
in 1 ml of leucine-free DMEM for times specified in the figure
legends. Ten percent trichloroacetic acid was added to terminate
incorporation. Wells were washed in water and 88% formic acid
was added to solubilize the trichloroacetic acid-insoluble proteins.
The samples were counted in a liquid scintillation counter. In each
experiment, triplicate wells were used per experimental point.
Statistical Analysis
Individual groups were compared using unpaired t test analysis
and were interpreted in a two-tailed manner.
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